Warm Autoimmune Hemolytic Anemia (DBCOND0048580)

Identifiers

Synonyms

Warm Autoimmune Hemolytic Anemia (WAIHA) / Warm Antibody Autoimmune Hemolytic Anemia / Warm autoimmune hemolytic anemia / Warm autoimmune haemolytic anaemia / Warm type hemolytic anemia / Warm autoimmune hemolytic anemia (disorder) / Warm type haemolytic anaemia

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04119050	Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia	Nipocalimab	treatment	2 / 3	recruiting
NCT05786573	A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)	Obexelimab	treatment	3	recruiting
NCT05757570	An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias	Povetacicept	treatment	1 / 2	recruiting
NCT04253236	To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).	No drug interventions	treatment	2	terminated
NCT05922839	Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA	Zanubrutinib	treatment	2	recruiting
NCT04956276	Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia	Orilanolimab	treatment	2	withdrawn
NCT05925023	Sirolimus in the Treatment of Refractory/Relapsed wAIHA	Sirolimus	treatment	2	recruiting
NCT01181154	Rituximab in Auto-Immune Hemolytic Anemia	Rituximab	treatment	3	completed
NCT03075878	A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)	Orilanolimab	treatment	1 / 2	terminated
NCT03226678	Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)	Pegcetacoplan	treatment	2	completed
NCT05221619	Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)	Nipocalimab	Not Available	Not Available	temporarily_not_available
NCT03965624	Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia	Ixazomib	treatment	2	withdrawn
NCT04256148	ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia	Orilanolimab	treatment	2	withdrawn
NCT05648968	A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia	Ianalumab	treatment	3	recruiting
NCT04661033	Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)	Isatuximab	treatment	2	terminated
NCT04691570	Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)	ANX-005	treatment	2	completed
NCT05073458	Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia	Parsaclisib	treatment	3	terminated
NCT02502903	Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders	No drug interventions	treatment	1	completed
NCT05002777	Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)	Rilzabrutinib	treatment	2	active_not_recruiting
NCT05535933	HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia	Sovleplenib	treatment	2 / 3	recruiting
NCT04138927	A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia	Fostamatinib	treatment	3	enrolling_by_invitation
NCT03764618	A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA	Fostamatinib	treatment	3	completed
NCT02612558	A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)	Fostamatinib	treatment	2	completed
NCT04657094	Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia	Acalabrutinib Tyrosine	treatment	2	active_not_recruiting